Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 220

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: A systematic review and meta‐analysis

Open access
Eusebi, Paolo, Giannandrea, David, Biscetti, Leonardo, Abraha, Iosief, Chiasserini, Davide, Orso, Massimiliano, Calabresi, Paolo, Parnetti, Lucilla · 2017 · Movement Disorders

Abstract

Background: The accumulation of misfolded α‐synuclein aggregates is associated with PD. However, the diagnostic value of the α‐synuclein levels in CSF is still under investigation. Methods: A comprehensive search of the literature was performed, yielding 34 studies eligible for meta‐analysis. We included studies that reported data on CSF total, oligomeric and phosphorylated α‐synuclein in patients with PD and healthy participants, neurological controls, or other parkinsonisms. Standardized mean differences were pooled using random‐effects models, and heterogeneity was reported as I 2. Bivariate random effects meta‐analysis was also performed on diagnostic data. Methodological quality of the selected studies was assessed using the QUADAS‐2 tool. Results: Concentrations of α‐synuclein species in PD did not show significant differences with respect to the levels found in other parkinsonisms. Total α‐synuclein was significantly reduced in PD when compared with controls (standardized mean differences −0.48; P < .001, I 2 = 60%). Oligomeric (standardized mean differences 0.57; P < .001, I 2 = 44%) and phosphorylated α‐synuclein (standardized mean differences 0.86; P < .001) were significantly increased in PD when compared with controls. Sensitivity and specificity for distinguishing PD and controls were 0.72 and 0.65, respectively, for total α‐synuclein, and 0.71 and 0.64, respectively, for oligomeric α‐syn. Conclusion: Most of the studies were at high risk of bias and have concerns regarding applicability. Diagnostic performance of CSF α‐synuclein species is still below what would be considered acceptable for their introduction in clinical practice. Future research should focus on combining α‐synuclein species with other biochemical markers as well on improving the standardization of current assays. © 2017 International Parkinson and Movement Disorder Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.27110

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 220

Metadata

Authors
Eusebi, P., Giannandrea, D., Biscetti, L., Abraha, I., Chiasserini, D., Orso, M., Calabresi, P., & Parnetti, L.
Venue
Movement Disorders
Publisher
Wiley
Published
2017-09-07
Volume
32
Issue
10
Pages
1389-1400
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2752721656
Cited by
220
References
13
FWCI
2.80
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: A systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1002/mds.27110
The paper
Eusebi, P., Giannandrea, D., Biscetti, L., Abraha, I., Chiasserini, D., Orso, M., Calabresi, P., & Parnetti, L. (2017). Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: A systematic review and meta‐analysis. Movement Disorders. https://doi.org/10.1002/mds.27110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.